Thiogenesis Therapeutics Corp (TTI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 732 | 853 | 2,126 | 1,095 | 878 |
| Operating Income | -732 | -853 | -2,126 | -1,095 | -878 |
| Other Income | 80 | 143 | 54 | 41 | 8 |
| Pre-tax Income | -651 | -711 | -2,071 | -1,055 | -870 |
| Net Income Continuous | -651 | -711 | -2,071 | -1,055 | -870 |
| Net Income | $-651 | $-711 | $-2,071 | $-1,055 | $-870 |
| EPS Basic Total Ops | -0.01 | -0.02 | -0.05 | -0.03 | -0.02 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | -0.05 | -0.03 | -0.02 |
| EPS Diluted Total Ops | -0.01 | -0.02 | -0.05 | -0.03 | -0.02 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.05 | -0.03 | -0.02 |
| EBITDA(a) | $-732 | $-853 | $-2,071 | $-1,055 | $-870 |